Search clinical trials for: MMS

Total 3091 results

Bristol-Myers Squibb
Exelixis

Terminated

A Study of BMS-863233 in Patients With Hematologic Cancer

Refractory Hematologic Cancer

United States
AstraZeneca

Completed

"Me and My Heart" Study (eMocial)

Acute Coronary Syndrome

Germany
Bristol-Myers Squibb

Completed

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Mexico, Australia, Colombia, Chile, Peru
Bristol-Myers Squibb

Terminated

Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease

Diabetic Kidney Disease

United States, Canada, Denmark, France
Prof. Dr. Frank Mooren

Completed

Whole-body Electromyostimulation in Inpatient Rehabilitation (GERKO)

Sarcopenia

Germany
Biogen

Completed

A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study of Intravenously Administered BMS-986168 in Healthy Subjects

Tauopathies

United States
University of Erlangen-Nürnberg Medical School

Unknown

Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant Diseases (FREEDOM)

Inflammation | Cancer | Muscular Atrophy | Cancer Cachexia

Germany
Juno Therapeutics, Inc., a Bristol-Myers Squibb...

Recruiting

A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of BMS-986393 in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States, Canada
Bristol-Myers Squibb

Completed

A Study to Evaluate BMS-986036 in Obese Adults With Type-2 Diabetes

Diabetes Mellitus Type 2

United States, Canada
Bristol-Myers Squibb

Completed

Japanese Phase 1 Multiple Ascending Dose Study

Type 2 Diabetes Mellitus

Japan
Health Ever Bio-Tech Co., Ltd.

Terminated

Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia (MCS_MOS)

Male Oligoasthenospermia

Taiwan
Mackay Memorial Hospital

Terminated

Electric Muscle Stimulation for Patients With Chronic Respiratory Failure

Critical Illness Myopathy | Chronic Respiratory Failure

Taiwan
Orlucent, Inc
Hadassah Medical Organization

Completed

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Skin Lesion

Israel
Bristol-Myers Squibb

Completed

A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult Participants

Healthy Volunteers

United States
CSL Behring

Terminated

Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease

Crohn's Disease

Germany, India, Korea, Republic of, Taiwan, United States, Hong Kong, Canada, Mexico, Austria, Switzerland, Israel, Italy, France, Poland, Netherlands, Hungary, Czechia, United Kingdom
The Immunobiological Technology Institute (Bio-Manguinhos)...
GlaxoSmithKline

Completed

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Measles | Rubella | Mumps | Varicella

Brazil
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Childhood Myelodysplastic Syndromes | Previously Treated Myelodysplastic Syndromes | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Myeloid... and other conditions

United States
Bristol-Myers Squibb

Completed

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP (ITP)

Immune Thrombocytopenic Purpura

United States, Australia, United Kingdom, Canada, Georgia, Moldova, Republic of, Poland, Russian Federation
Peking University People's Hospital

Unknown

Natural Killer Cells Reconstitution Kinetics Post Haploidentical Transplantation

Natural Killer Cell Mediated Immunity

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Prospective Registration of mOrbidity and Mortality, individUal radioSensitivity and Radiation Technique (PROUST) (PROUST)

Radiotherapy
Ludwig-Maximilians - University of Munich
King's College London; University of Cambridge; Helmholtz Zentrum München; University...

Completed

Evaluation of a Multi-professional Breathlessness Service for Patients With Breathlessness Due to Any Advanced Disease (BreathEase)

Cancer | Chronic Heart Failure | Interstitial Lung Disease | COPD | Breathlessness

Germany
UroGen Pharma Ltd.

Completed

Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC (OPTIMA)

Carcinoma of Urinary Bladder, Superficial

Israel, Spain, Italy, Switzerland
Robin, Alan L., M.D.
Alcon Research

Unknown

Observational Study of How Patients Take Eye Drops

Glaucoma

United States
Alba Maria Ropero
Centers for Disease Control and Prevention; Ministry of Public Health, Argentina

Completed

Immunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) Vaccines

Vaccine Response Impaired

Argentina
University of Erlangen-Nürnberg Medical School
University of Erlangen-Nürnberg

Withdrawn

Effects of WB-EMS in Ulcerative Colitis Patients

Ulcerative Colitis

Germany
National Cancer Institute (NCI)

Completed

BMS-214662 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Bristol-Myers Squibb

Withdrawn

Evaluate the Bioavailability Between 2 BMS-986141 Formulations in Healthy Participants

Healthy
Sahlgrenska University Hospital, Sweden
Lund University

Recruiting

Magnetomotoric Ultrasound for Diagnostic Purposes in Rectal Cancer (MMURC)

Rectal Cancer

Sweden
Sanoculis Ltd

Completed

Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure - Performance Evaluation Study

This Study is Conducted Under Inclusion/ Exclusion Criteria

Armenia
Shahid Beheshti University of Medical Sciences

Unknown

Bleb Function and Morphology With Intratendon Injection of MMC Compared With Standard Method (conj mmc)

Glaucoma

Iran, Islamic Republic of
Blood Transfusion Centre of Slovenia

Unknown

Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma (SYSTHER)

Pancreatic Tubular Adenocarcinoma

Slovenia
Bristol-Myers Squibb

Completed

A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma

Multiple Myeloma

United States, Spain
Bristol-Myers Squibb

Recruiting

A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

United States
The University of Hong Kong
Caritas Medical Centre, Hong Kong

Not yet recruiting

A Brief Body-mind-spirit Intervention to Promote Positive Emotions

Stress | Emotions
Liverpool John Moores University

Completed

A Comparison of Acute Psychobiological Responses to Laboratory Stress Tests

Stress, Psychological | Stress, Physiological

United Kingdom
Liverpool John Moores University
Danone Nutricia Research

Completed

Assessing the Repeatability of a Psychological Stress Test

Stress, Psychological | Stress, Physiological

United Kingdom
Bristol-Myers Squibb

Withdrawn

A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants

Healthy Adult Volunteers
Bristol-Myers Squibb

Completed

A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BMS-986369 in Healthy Participants

Healthy Volunteer

United States
Yale University
National Institute on Aging (NIA)

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923

Alzheimer Disease

United States
Matthew Dallos
Bristol-Myers Squibb

Terminated

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Solid Tumor | Sars-CoV2 | Hematological Malignancy

United States
Bristol-Myers Squibb

Completed

Phase 1 Study of Mesothelin-ADC

Advanced Cancer

Japan
Bristol-Myers Squibb

Completed

An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants

Cardiac Failure | Myocardial Failure

United States
Bristol-Myers Squibb

Completed

A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function

Renal Failure | Congestive Heart Failure | Kidney Failure | Cardiac Failure | Myocardial Failure

Poland, Czechia
University of Minnesota

Completed

Pressure-Volume Measurements on the AMS 800TM Cuff (AUS)

Stress Urinary Incontinence

United States
Bristol-Myers Squibb

Completed

Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

Thrombosis

United Kingdom
Bristol-Myers Squibb

Terminated

Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial

Healthy

United States
Bristol-Myers Squibb

Completed

A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment

Thrombosis | Renal Impairment | Factor XI | ESRD (End-Stage Renal Disease)

United States
Erchonia Corporation

Terminated

Study of the Effect of Low Level Laser Light on Hair Growth on the Female Human Scalp

Female Pattern Alopecia

United States
Bristol-Myers Squibb

Completed

Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic Impairment

Hepatic Insufficiency

United States
Biotronik AG

Completed

First in Man Trial - BIOSOLVE-I (BIOSOLVE-I)

de Novo Lesions in Native Coronary Arteries

Netherlands, Switzerland, Germany, Belgium

Search clinical trials for: MMS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations